Blood Eosinophil–directed Management of Airway Disease. The Past, Present, and Future

por Pavord, Ian D.
Publicado 2020

Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease

por Bush, Andrew, Pavord, Ian D.
Publicado 2021

Reply to: Challenging the paradigm

por Bush, Andrew, Pavord, Ian D.
Publicado 2022

Living without eosinophils: evidence from mouse and man

por Jackson, David J., Pavord, Ian D.
Publicado 2023

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight

por Howell, Imran, Howell, Aleksandra, Pavord, Ian D.
Publicado 2023

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma

por Pavord, Ian, Woodcock, Ashley, Parker, Debbie, Rice, Leanne
Publicado 2007

Asthma in pregnancy: An update

por Couillard, Simon, Connolly, Clare, Borg, Catherine, Pavord, Ian
Publicado 2020

Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta...

por Couillard, Simon, Steyerberg, Ewout, Beasley, Richard, Pavord, Ian
Publicado 2022

Fractional exhaled nitric oxide (FeNO): the future of asthma care?

por Wang, Kay, Stonham, Carol, Rutherford, Christine, Pavord, Ian D
Publicado 2023

Step 4: stick or twist? A review of asthma therapy

por Slater, Mariel G, Pavord, Ian D, Shaw, Dominick E
Publicado 2016

The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute)

por Yousaf, Nadia, Lee, Kai K, Jayaraman, Bhagyashree, Pavord, Ian D, Birring, Surinder S
Publicado 2011

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial

por Siva, Roshan, Bafadhel, Mona, Monteiro, William, Brightling, Christopher E, Pavord, Ian D
Publicado 2014

Exacerbations of COPD

por Pavord, Ian D, Jones, Paul W, Burgel, Pierre-Régis, Rabe, Klaus F
Publicado 2016

Asthma remission: what is it and how can it be achieved?

por Thomas, Dennis, McDonald, Vanessa M., Pavord, Ian D., Gibson, Peter G.
Publicado 2022

Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms

por Singh, Dave, Oosterholt, Sean, Pavord, Ian, Garcia, Gabriel, Abhijith PG, Della Pasqua, Oscar
Publicado 2023

Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”

por Samuelsen, Carl, Bateman, Eric D., Pavord, Ian, Lloyd, Adam, Baldwin, Mike, Esser, Dirk
Publicado 2015

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β(2)-agonists in the United Kingdom: a cross-sectional analysis

por Pavord, Ian D., Mathieson, Nicola, Scowcroft, Anna, Pedersini, Riccardo, Isherwood, Gina, Price, David
Publicado 2017

Author Correction: The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β(2)-agonists in the United Kingdom: a cross-sectio...

por Pavord, Ian D., Mathieson, Nicola, Scowcroft, Anna, Pedersini, Riccardo, Isherwood, Gina, Price, David
Publicado 2017

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma

por Beasley, Richard, Harper, James, Bird, Grace, Maijers, Ingrid, Weatherall, Mark, Pavord, Ian D.
Publicado 2019

Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework

por Couillard, Simon, Pavord, Ian D., Heaney, Liam G., Petousi, Nayia, Hinks, Timothy S. C.
Publicado 2022